美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Cyclerion Therapeutics, Inc.

26.20

+2.6811.39%

盤前：26.200.00000.00%04:01 EDT

成交量：2.80萬

成交額：65.59萬

市值：1,752.26萬

市盈率：-2.16

高：26.20

開：21.20

低：21.00

收：23.52

52周最高：59.36

52周最低：7.19

股本：66.88萬

流通股本：24.07萬

量比：1.05

換手率：11.64%

股息：- -

股息率：- -

每股收益(TTM):-12.1293

每股收益(LYR):-7.7700

淨資產收益率：--

總資產收益率：--

市淨率：--

市盈率(LYR):-3.37

資料載入中...

總覽公司新聞公告

公司資料

公司名字：

Cyclerion Therapeutics, Inc.

交易所：

NASDAQ

成立時間：

2024

員工人數：

- -

公司地址：

221 Crescent Street,Building 23,Suite 105,Waltham,Massachusetts,United States

官網：

http://www.cyclerion.com

郵編：

02453

電話：

傳真：

- -

簡介：

Cyclerion Therapeutics, Inc.於2018年9月6日在馬薩諸塞州註冊成立。Cyclerion是一家生物製藥公司，專註於在中樞神經系統和外周使用新型可溶性鳥苷酸環化酶刺激劑治療嚴重疾病。一氧化氮sGC環鳥苷一磷酸信號通路是精確控制全身生理關鍵方面的根本機制。NO-SGC-cGMP通路調節CNS和外周的多種關鍵生物學功能，已成功地被幾種藥物靶向。

董事

名稱

職位

Jonathan Violin

Chief Executive Officer and Director and President

Andrew Gottesdiener

Director

Heidi Henson

Director

Michelle Pernice

Director

Nimish Shah

Director

Tomas Kiselak

Director

股東

名稱

職位

Jonathan Violin

Chief Executive Officer and Director and President

Mark Vignola

Chief Financial Officer

Madelyn Zeylikman

General Counsel and Secretary

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hant/stock/KRSA/company"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"KRSA","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"KRSA\",,,,,undefined,":{"symbol":"KRSA","market":"US","secType":"STK","nameCN":"Cyclerion Therapeutics, Inc.","latestPrice":26.2,"timestamp":1788984000000,"preClose":23.52,"halted":0,"volume":28025,"hourTrading":{"tag":"盘前","latestPrice":26.2,"preClose":26.2,"latestTime":"04:01 EDT","volume":30,"amount":783,"timestamp":1789027262863,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.1139455782312925,"floatShares":240679,"shares":668800,"eps":-12.129334,"marketStatus":"盤前交易","change":2.68,"latestTime":"09-10 04:27:02 EDT","open":21.2,"high":26.2,"low":21.0001,"amount":655933.168175,"amplitude":0.221084,"askPrice":28.98,"askSize":100,"bidPrice":17.38,"bidSize":100,"shortable":0,"etf":0,"ttmEps":-12.129334,"tradingStatus":1,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1789047000000},"marketStatusCode":1,"adr":0,"exchange":"NASDAQ","adjPreClose":26.2,"preHourTrading":{"tag":"盘前","latestPrice":26.2,"preClose":26.2,"latestTime":"04:01 EDT","volume":30,"amount":783,"timestamp":1789027262863,"change":0,"changeRate":0,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":24.26,"preClose":26.2,"latestTime":"19:55 EDT","volume":1463,"amount":37015.4622,"timestamp":1788998115597,"change":-1.94,"changeRate":-0.074046,"amplitude":0.074046},"volumeRatio":1.0546974918121717},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"KRSA\",,,,,undefined,":{"symbol":"KRSA","floatShares":240679,"roa":"--","roe":"--","lyrEps":-7.77,"volumeRatio":1.054697,"shares":668800,"dividePrice":0,"high":26.2,"amplitude":0.221084,"preClose":23.52,"low":21.0001,"week52Low":7.1862,"pbRate":"--","week52High":59.36,"institutionHeld":0,"latestPrice":26.2,"eps":-12.129334,"divideRate":0,"volume":28025,"delay":0,"ttmEps":-12.129334,"open":21.2,"prevYearClose":1.27,"prevWeekClose":4.25,"prevMonthClose":3.68,"prevQuarterClose":3.39,"fiveDayClose":4.17,"twentyDayClose":3.57,"sixtyDayClose":3.25},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/KRSA\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-09-09","symbol":"KRSA","defaultRemindTime":1788960600000,"type":"split","dateTimestamp":1788926400000,"forFactor":7,"toFactor":1,"ratio":7}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"KRSA\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"KRSA\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":1966002000,"yearFounded":2024,"address":"221 Crescent Street,Building 23,Suite 105,Waltham,Massachusetts,United States","zipCode":"02453","officePhone":"(781) 516-2325"},"stockCompanyDetail":{"websiteUrl":"http://www.cyclerion.com","stockEarnings":[{"period":"1week","weight":4.7965},{"period":"1month","weight":6.3184},{"period":"3month","weight":7.162},{"period":"6month","weight":17.069},{"period":"1year","weight":9.0769},{"period":"ytd","weight":19.6299}],"compareEarnings":[{"period":"1week","weight":-0.0036},{"period":"1month","weight":-0.0138},{"period":"3month","weight":0.0334},{"period":"6month","weight":0.1512},{"period":"1year","weight":0.1723},{"period":"ytd","weight":0.118}],"compareStock":{"symbol":"SPY","name":"標普500ETF"},"description":"Cyclerion Therapeutics, Inc.於2018年9月6日在馬薩諸塞州註冊成立。Cyclerion是一家生物製藥公司，專註於在中樞神經系統和外周使用新型可溶性鳥苷酸環化酶刺激劑治療嚴重疾病。一氧化氮sGC環鳥苷一磷酸信號通路是精確控制全身生理關鍵方面的根本機制。NO-SGC-cGMP通路調節CNS和外周的多種關鍵生物學功能，已成功地被幾種藥物靶向。","yearOnYearQuotes":[{"month":1,"riseRate":0.714286,"avgChangeRate":0.030269},{"month":2,"riseRate":0.285714,"avgChangeRate":-0.005726},{"month":3,"riseRate":0.428571,"avgChangeRate":-0.111354},{"month":4,"riseRate":0.428571,"avgChangeRate":0.134457},{"month":5,"riseRate":0.25,"avgChangeRate":-0.02829},{"month":6,"riseRate":0.5,"avgChangeRate":0.038893},{"month":7,"riseRate":0.375,"avgChangeRate":0.026358},{"month":8,"riseRate":0.625,"avgChangeRate":0.100341},{"month":9,"riseRate":0.375,"avgChangeRate":0.746845},{"month":10,"riseRate":0.142857,"avgChangeRate":-0.324291},{"month":11,"riseRate":0.285714,"avgChangeRate":0.0186},{"month":12,"riseRate":0.428571,"avgChangeRate":0.106805}],"exchange":"NASDAQ","name":"Cyclerion Therapeutics, Inc.","nameEN":"Cyclerion Therapeutics, Inc."}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"KRSA\",market:\"US\",,,undefined,":{"directors":[{"name":"Jonathan Violin","position":"Chief Executive Officer and Director and President"},{"name":"Andrew Gottesdiener","position":"Director"},{"name":"Heidi Henson","position":"Director"},{"name":"Michelle Pernice","position":"Director"},{"name":"Nimish Shah","position":"Director"},{"name":"Tomas Kiselak","position":"Director"}],"executives":[{"name":"Jonathan Violin","position":"Chief Executive Officer and Director and President"},{"name":"Mark Vignola","position":"Chief Financial Officer"},{"name":"Madelyn Zeylikman","position":"General Counsel and Secretary"}]}}}